GPT and metabolic dysfunction-associated steatotic liver disease: Furthermore, a research done by Singh et al. examining 4899 T1D patients aged 18–80 year with suspected NAFLD; showed a prevalence of advanced fibrosis of 22.1% using AST/ALT > 1.4, demonstrating increased risk to develop progressive hepatic affection and its associated complications [10].